Find a Clinical Trial

Find a clinical trial underway at the OSUCCC – James.

Search by Keyword

(i.e. John Smith, 197102, Phase 3)

Showing 1-10 of 16

Filtered By: melanoma

Open To Accrual

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Protocol NumberOSU-23427

Open To Accrual

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Protocol NumberECOG-ACRIN-EA6192

Open To Accrual

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors

Protocol NumberOSU-24113

Open To Accrual

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Protocol NumberSWOG-S2015

Open To Accrual

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Protocol NumberOSU-24154

Open To Accrual

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Protocol NumberOSU-21076

Open To Accrual

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Protocol NumberOSU-23388

Open To Accrual

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

Protocol NumberOSU-23046

Open To Accrual

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Protocol NumberNRG-GY022

Open To Accrual

XTX301 in Patients With Advanced Solid Tumors

Protocol NumberOSU-23325